向瘤免疫微环境:GPCRs作为三阴性乳腺癌的关键调节剂
Chengyi Wang1, Yanyan Liu1, Ru Zhang1
1Clinical Medical School, Jining Medical University, Jining, China.
International immunopharmacology
|December 31, 2024
概括
G蛋白结合受体 (GPCR) 在三阴性乳腺癌 (TNBC) 中显著影响瘤免疫微环境. 针对这些GPCRs为TNBC治疗提供了有前途的新免疫疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 三阴性乳腺癌 (TNBC) 具有侵略性,治疗选择有限.
- G蛋白结合受体 (GPCRs) 在TNBC的瘤免疫微环境 (TIME) 中发挥着至关重要的作用.
- GPCRs影响免疫细胞活动,促进免疫抑制环境,有助于瘤生长和转移.
研究的目的:
- 审查TNBC中四个关键GPCRs (化学因子,斯芬戈辛-1-酸盐,前列腺素E2和乳酸受体) 的作用.
- 检查免疫细胞上的GPCR表达如何影响TNBC病变发生.
- 讨论针对TNBC免疫治疗的GPCRs的新型治疗策略.
主要方法:
- 对TNBC中GPCR研究的文献综述.
- 在TNBC TIME中分析GPCR表达和功能.
- 探索针对GPCR信号通路的治疗干预措施.
主要成果:
- GPCRs调节免疫细胞的招募,两极分化,并在TNBC微环境中起作用.
- 改变的GPCR表达有助于TNBC的进展和转移.
- 准GPCRs可能会重塑免疫抑制的时间.
结论:
- GPCRs是TNBC中免疫反应的关键调节者.
- 了解GPCR介导的免疫调节为TNBC病理生理学提供了洞察力.
- 向GPCRs是开发新型TNBC免疫疗法的有希望的策略.
更多相关视频
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.5K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
